Healthcare provider profile · identity verified

Sumaira Ali, M.D.

Internal Medicine · WESTERLY, RI · NPI 1841236270

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	413	105
Levothyroxine Sodium	Levothyroxine Sodium	393	101
Atorvastatin Calcium	Atorvastatin Calcium	369	104
Lisinopril	Lisinopril	315	90
Rosuvastatin Calcium	Rosuvastatin Calcium	255	81
Losartan Potassium	Losartan Potassium	232	67
Metoprolol Succinate	Metoprolol Succinate	222	53
Gabapentin	Gabapentin	218	55
Albuterol Sulfate Hfa	Albuterol Sulfate	187	56
Omeprazole	Omeprazole	161	48
Furosemide	Furosemide	157	33
Pantoprazole Sodium	Pantoprazole Sodium	148	41
Ozempic	Semaglutide	142	24
Trazodone Hcl	Trazodone Hcl	142	35
Hydrochlorothiazide	Hydrochlorothiazide	117	34
Duloxetine Hcl	Duloxetine Hcl	116	24
Zolpidem Tartrate	Zolpidem Tartrate	115	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	112	22
Metformin Hcl Er	Metformin Hcl	101	35
Metformin Hcl	Metformin Hcl	95	32
Pravastatin Sodium	Pravastatin Sodium	91	20
Sertraline Hcl	Sertraline Hcl	85	26
Clopidogrel	Clopidogrel Bisulfate	84	19
Meloxicam	Meloxicam	83	27
Fluticasone Propionate	Fluticasone Propionate	80	34
Simvastatin	Simvastatin	80	25
Allopurinol	Allopurinol	76	22
Eliquis	Apixaban	76	16
Montelukast Sodium	Montelukast Sodium	70	26
Tramadol Hcl	Tramadol Hcl	69	18
Bupropion Xl	Bupropion Hcl	64	18
Prednisone	Prednisone	64	42
Venlafaxine Hcl Er	Venlafaxine Hcl	63	15
Alprazolam	Alprazolam	60	24
Atenolol	Atenolol	60	20
Buspirone Hcl	Buspirone Hcl	58	16
Potassium Chloride	Potassium Chloride	58	17
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Escitalopram Oxalate	Escitalopram Oxalate	57	19
Pregabalin	Pregabalin	56	19
Famotidine	Famotidine	54	21
Fluoxetine Hcl	Fluoxetine Hcl	54	17
Olmesartan Medoxomil	Olmesartan Medoxomil	54	12
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Synthroid	Levothyroxine Sodium	50	14
Carvedilol	Carvedilol	48	11
Clonazepam	Clonazepam	48	13
Glipizide Er	Glipizide	46	14
Finasteride	Finasteride	43	suppressed
Azelastine Hcl	Azelastine Hcl	40	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	14
Lorazepam	Lorazepam	38	15
Azithromycin	Azithromycin	34	32
Tradjenta	Linagliptin	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	18
Lovastatin	Lovastatin	33	suppressed
Ezetimibe	Ezetimibe	32	13
Mirtazapine	Mirtazapine	32	11
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Glimepiride	Glimepiride	31	11
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	23
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Torsemide	Torsemide	28	suppressed
Diazepam	Diazepam	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	11
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	14
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Baclofen	Baclofen	17	suppressed
Mupirocin	Mupirocin	17	14
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Valsartan	Valsartan	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Cephalexin	Cephalexin	15	12
Latanoprost	Latanoprost	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Quinine Sulfate	Quinine Sulfate	13	suppressed
Topiramate	Topiramate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nystatin	Nystatin	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Estradiol	Estradiol	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error